These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 29909760)

  • 1. [Epidemiology, etiology and treatment of patients with psychosis and co-morbid substance use disorder].
    Moggi F
    Ther Umsch; 2018 Jun; 75(1):37-43. PubMed ID: 29909760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
    Horsfall J; Cleary M; Hunt GE; Walter G
    Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dual diagnosis of psychosis and addiction. From principles to practice].
    Gouzoulis-Mayfrank E
    Nervenarzt; 2004 Jul; 75(7):642-50. PubMed ID: 15293008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dual diagnosis psychosis and substance use disorders: theoretical foundations and treatment].
    Gouzoulis-Mayfrank E
    Z Kinder Jugendpsychiatr Psychother; 2008 Jul; 36(4):245-53. PubMed ID: 18654956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of psychosis remission in psychotic disorders that co-occur with substance use.
    Caton CL; Hasin DS; Shrout PE; Drake RE; Dominguez B; Samet S; Schanzer B
    Schizophr Bull; 2006 Oct; 32(4):618-25. PubMed ID: 16873441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reasons for increased substance use in psychosis.
    Gregg L; Barrowclough C; Haddock G
    Clin Psychol Rev; 2007 May; 27(4):494-510. PubMed ID: 17240501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies.
    Baker A; Bucci S; Lewin TJ; Richmond R; Carr VJ
    Psychiatry Res; 2005 Apr; 134(3):241-50. PubMed ID: 15892983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
    Green AI
    J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term course of substance use disorders among patients with severe mental illness.
    Bartels SJ; Drake RE; Wallach MA
    Psychiatr Serv; 1995 Mar; 46(3):248-51. PubMed ID: 7796211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuing care after inpatient psychiatric treatment for patients with psychiatric and substance use disorders.
    Ilgen MA; Hu KU; Moos RH; McKellar J
    Psychiatr Serv; 2008 Sep; 59(9):982-8. PubMed ID: 18757590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of the Effects of an Intervention Aiming to Link Patients Receiving Addiction Treatment With Health Care: The LINKAGE Clinical Trial.
    Weisner CM; Chi FW; Lu Y; Ross TB; Wood SB; Hinman A; Pating D; Satre D; Sterling SA
    JAMA Psychiatry; 2016 Aug; 73(8):804-14. PubMed ID: 27332703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
    San L; Arranz B; Martinez-Raga J
    Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical comorbidity in patients with schizophrenia and alcohol dependence.
    Batki SL; Meszaros ZS; Strutynski K; Dimmock JA; Leontieva L; Ploutz-Snyder R; Canfield K; Drayer RA
    Schizophr Res; 2009 Feb; 107(2-3):139-46. PubMed ID: 19022627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidity of schizophrenia and substance abuse: implications for treatment.
    Mueser KT; Bellack AS; Blanchard JJ
    J Consult Clin Psychol; 1992 Dec; 60(6):845-56. PubMed ID: 1460148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroimaging in substance abuse disorders].
    de Mendelssohn A; Kasper S; Tauscher J
    Nervenarzt; 2004 Jul; 75(7):651-62. PubMed ID: 15300321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbid schizophrenia and substance abuse.
    Green AI; Brown ES
    J Clin Psychiatry; 2006 Sep; 67(9):e08. PubMed ID: 17081075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse.
    Møller T; Linaker OM
    Nord J Psychiatry; 2004; 58(3):237-42. PubMed ID: 15204212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Attributable risk of co-morbid substance use disorder in poor observance to pharmacological treatment and the occurrence of relapse in schizophrenia].
    Ameller A; Gorwood P
    Encephale; 2015 Apr; 41(2):174-83. PubMed ID: 25838239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment.
    Arndt S; Tyrrell G; Flaum M; Andreasen NC
    Psychol Med; 1992 May; 22(2):379-88. PubMed ID: 1615105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.